Back to Search
Start Over
Study Data from University of Laval Provide New Insights into Prostate Cancer (Isocitrate Dehydrogenase 1 Sustains a Hybrid Cytoplasmic-mitochondrial Tricarboxylic Acid Cycle That Can Be Targeted for Therapeutic Purposes In Prostate Cancer).
- Source :
- Drug Week; 8/25/2023, p1110-1110, 1p
- Publication Year :
- 2023
-
Abstract
- Mouse models, in vitro human PCa cell lines, and human patient-derived organoids (PDOs) were used to study the expression and activity of IDH enzymes in the normal prostate and PCa. Keywords: Quebec City; Canada; North and Central America; Acyclic Acids; Alcohol Oxidoreductases; Cancer; Carboxylic Acids; Cell Proliferation; Citrates; Cytoplasm; Dehydrogenase; Drugs and Therapies; Enzymes and Coenzymes; Health and Medicine; Intracellular Space; Isocitrate Dehydrogenase; Isocitrates; Oncology; Organic Chemicals; Prostate Cancer; Prostatic Neoplasms; Therapeutics; Therapy; Tricarboxylic Acids EN Quebec City Canada North and Central America Acyclic Acids Alcohol Oxidoreductases Cancer Carboxylic Acids Cell Proliferation Citrates Cytoplasm Dehydrogenase Drugs and Therapies Enzymes and Coenzymes Health and Medicine Intracellular Space Isocitrate Dehydrogenase Isocitrates Oncology Organic Chemicals Prostate Cancer Prostatic Neoplasms Therapeutics Therapy Tricarboxylic Acids 1110 1110 1 08/21/23 20230825 NES 230825 2023 AUG 22 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Researchers detail new data in Oncology - Prostate Cancer. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 15316440
- Database :
- Supplemental Index
- Journal :
- Drug Week
- Publication Type :
- Periodical
- Accession number :
- 169996886